178556-45-1

Upstream product

• 343326-75-0 methyl 2-(4-chloro-3-nitrophenyl)-2-methylpropanoate 
• 55770-68-8 2-(4-chloro-3-nitrophenyl)-2-methylpropanenitrile 
• 30568-32-2 2-(4-chlorophenyl)-2-methylpropanenitrile 
• 6258-30-6 2-(4-chlorophenyl)-2-methylpropanoic acid 

Downstream Products

• 103096-01-1 2-(3-aminophenyl)-2-methylpropionic acid hydrochloride 
• 848846-71-9 methyl 2-(3-amino-4-chlorophenyl)-2-methylpropanoate 
• 848846-61-7 2-{4-chloro-3-[(2,6-dimethyl-4-{[(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methoxy}benzoyl)amino]phenyl}-2-methylpropanoic acid 
• 848846-62-8 2-{4-chloro-3-[(2,5-dimethyl-4-{[(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methoxy}benzoyl)amino]phenyl}-2-methylpropanoic acid 
• 848846-58-2 2-{4-chloro-3-[(2-chloro-4-{[(2S)-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-2-yl]methoxy}benzoyl)amino]phenyl}-2-methylpropanoic acid 
• 343326-75-0 methyl 2-(4-chloro-3-nitrophenyl)-2-methylpropanoate 
• 103204-32-6 2-(3-nitrophenyl)-2-methylpropionic acid 

Relevant academic research and scientific papers

Discovery of new orally active prostaglandin D2 receptor antagonists

To identify an orally available drug candidate, a series of 3-benzoylaminophenylacetic acids were synthesized and evaluated as prostaglandin D2 (PGD2) receptor antagonists. Some of the compounds tested were found to exhibit excellent

Calcium salts of 1,5-benzodiazepine derivatives, process for producing the salts and drugs containing the same

Provided are calcium salts of a 1,5-benzodiazepine derivative represented by the following formula (I): (wherein, R1 represents a lower alkyl group, R2 represents a phenyl or cyclohexyl group, and Y represents a single bond or a lowe

Process for the preparation of nitrobenzene derivatives

A method for preparing a compound of formula (I), wherein R1 and R2, which are the same or different, are a hydrogen atom or an alkyl or alkoxy radical, or R1 and R2, taken together with the carbon atom to which